Resultats de la cerca - Chin‐Yang Li

Refinar resultats
  1. 1
    Systemic mast cell disease: A clinical and hematopathologic study of 26 cases

    Systemic mast cell disease: A clinical and hematopathologic study of 26 cases per Thomas A. Webb, Chin‐Yang Li, Lung T. Yam

    Publicat 1982
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes

    Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes per Ronald S. Go, Chin‐Yang Li, Ayalew Tefferi, Robert L. Phyliky

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Treatment of Systemic Mast-Cell Disease with Cladribine

    Treatment of Systemic Mast-Cell Disease with Cladribine per Ayalew Tefferi, Chin‐Yang Li, Joseph H. Butterfield, H. Clark Hoagland

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  4. 4
    Epstein-Barr virus infection in Richter's transformation

    Epstein-Barr virus infection in Richter's transformation per Stephen M. Ansell, Chin‐Yang Li, Ricardo V. Lloyd, Robert L. Phyliky

    Publicat 1999
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon‐alpha, hydroxyurea, imatinib mesylate or 2‐chlorodeoxyadenosine

    Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon‐alpha, hydroxyurea, imatinib mesylate or 2... per Ken Hong Lim, Animesh Pardanani, Joseph H. Butterfield, Chin‐Yang Li, Ayalew Tefferi

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Systemic Mast Cell Disease

    Systemic Mast Cell Disease per William D. Travis, Chin‐Yang Li, Erik J. Bergstralh, Lung T. Yam, Ronald G. Swee

    Publicat 1988
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study

    Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study per David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Leigh A. Gray, Ayalew Tefferi

    Publicat 2002
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Significance of systemic mast cell disease with associated hematologic disorders

    Significance of systemic mast cell disease with associated hematologic disorders per William D. Travis, Chin‐Yang Li, Lung T. Yam, Erik J. Bergstralh, Ronald G. Swee

    Publicat 1988
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases

    Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases per Ruben A. Mesa, Chin‐Yang Li, Rhett P. Ketterling, Georgene Schroeder, Ryan A. Knudson, Ayalew Tefferi

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia

    Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia per Ayalew Tefferi, Ruben A. Mesa, Georgene Schroeder, Curtis A. Hanson, Chin‐Yang Li, Gordon W. Dewald

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Validation and comparison of contemporary prognostic models in primary myelofibrosis

    Validation and comparison of contemporary prognostic models in primary myelofibrosis per Ayalew Tefferi, Jocelin Huang, Susan M. Schwager, Chin‐Yang Li, Wenting Wu, Animesh Pardanani, Ruben A. Mesa

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Risk factors for leukemic transformation in patients with primary myelofibrosis

    Risk factors for leukemic transformation in patients with primary myelofibrosis per Jocelin Huang, Chin‐Yang Li, Ruben A. Mesa, Wentling Wu, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults

    WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults per Animesh Pardanani, Ken-Hong Lim, Terra L. Lasho, Christy Finke, Rebecca F. McClure, Chin‐Yang Li, Ayalew Tefferi

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Thalidomide treatment in myelofibrosis with myeloid metaplasia

    Thalidomide treatment in myelofibrosis with myeloid metaplasia per Michelle A. Elliott, Ruben A. Mesa, Chin‐Yang Li, C. Christopher Hook, Stephen M. Ansell, Ralph Levitt, Susan M. Geyer, Ayalew Tefferi

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    The <i>JAK2</i><sup>V617F</sup> tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates

    The <i>JAK2</i><sup>V617F</sup> tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates per Ayalew Tefferi, Terra L. Lasho, Susan M. Schwager, David P. Steensma, Ruben A. Mesa, Chin‐Yang Li, Martha Wadleigh, D. Gary Gilliland

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903

    Lenalidomide and prednisone for myelofibrosis: Eastern Cooperative Oncology Group (ECOG) phase 2 trial E4903 per Ruben A. Mesa, Xiaopan Yao, Larry D. Cripe, Chin Yang Li, Mark R. Litzow, Elisabeth Paietta, Jacob M. Rowe, Ayalew Tefferi, Martin S. Tallman

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

    Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors per Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Christy Finke, Mrinal M. Patnaik, Joseph H. Butterfield, Rebecca F. McClure, Chin‐Yang Li, Animesh Pardanani

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Clinical correlates of <i>JAK2</i>V617F allele burden in essential thrombocythemia

    Clinical correlates of <i>JAK2</i>V617F allele burden in essential thrombocythemia per Jaya Kittur, Ryan A. Knudson, Terra L. Lasho, Christy Finke, Naseema Gangat, Alexandra P. Wolanskyj, Chin‐Yang Li, Wenting Wu, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Concomitant neutrophil <i>JAK2</i><sup>V617F</sup> mutation screening and <i>PRV‐1</i> expression analysis in myeloproliferative disorders and secondary polycythaemia

    Concomitant neutrophil <i>JAK2</i><sup>V617F</sup> mutation screening and <i>PRV‐1</i> expression analysis in myeloproliferative disorders and secondary polycythaemia per Ayalew Tefferi, Shireen Sirhan, Terra L. Lasho, Susan M. Schwager, Chin‐Yang Li, David Dingli, Alexandra P. Wolanskyj, David P. Steensma, Ruben A. Mesa, D. Gary Gilliland

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia

    FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia per Animesh Pardanani, Stephanie R. Brockman, Sarah F. Paternoster, Heather C. Flynn, Rhett P. Ketterling, Terra L. Lasho, Ching-Liang Ho, Chin‐Yang Li, Gordon W. Dewald, Ayalew Tefferi

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: